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Objective: African Americans (AAs) are at risk for developing diabetes mellitus and atherosclerosis. Whether race
influences the results of infrainguinal arterial reconstruction is unclear. The purpose of this study was to compare the
results of autogenous infrainguinal bypasses in AAs and Caucasians to determine the association of race with graft
function and limb salvage.
Methods:This was a retrospective, comparative cohort study of AA andCaucasian patients who had undergone autogenous
infrainguinal bypass surgery. Only single-limb bypasses in each patient cohort were considered in this analysis. In patients
who had undergone bilateral lower limb bypasses, the first limb bypass was chosen as the index bypass procedure.
Results: From January 1985 to December 2003, 1459 autogenous infrainguinal bypasses were performed in 1459
patients for lower limb ischemia. Within this group, 89 AA patients/vein grafts formed the study cohort. The control
group comprised 1370 Caucasian patients/vein grafts. Compared with the Caucasian cohort, AA patients were
significantly younger (median age, 65 vs 70 years, respectively; P  .001) and predominantly female (57% vs 41%,
respectively; P  .002). AA patients also had a higher prevalence of diabetes mellitus, hypertension, cerebrovascular
disease, congestive heart failure, and dialysis-dependent renal failure. More AA than Caucasian patients presented with
gangrene (34% vs 16%, respectively; P  .001), and more underwent bypass surgery for limb salvage indications (91% vs
81%, respectively; P .01). The venous conduit used was predominantly the greater saphenous vein (AA, 83%; Caucasian,
85%), and the site of distal anastomosis was at the tibial/pedal level in 67% of AA and 61% of Caucasian patients. Overall
morbidity (AA, 28%; Caucasian, 23%) and 30-day mortality (AA, 3%; Caucasian, 3%) were similar. Thirty-day graft
failure was significantly greater in AAs than Caucasians (12% vs 5%, respectively; P  .003). The overall 5-year primary
graft patency (SE) was significantly worse in AA patients (AA, 52% 6%; Caucasian, 67% 2%; P .009). The 5-year
limb salvage rate (SE) was also significantly worse in AA patients (AA, 81% 5%; Caucasian, 90% 1%; P .04). With
the Cox proportional hazard model, significant risk factors associated with primary graft failure were AA race, age
younger than 65 years, female sex, secondary reconstructions, tibial bypasses, and critical limb ischemia. Significant risk
factors associated with limb loss were age younger than 65 years, female sex, absence of coronary disease, presence of
critical limb ischemia, and secondary reconstructions.
Conclusions: Autogenous infrainguinal bypass surgery in AAs is associated with poorer primary graft patency and limb
salvage rates compared with those of Caucasians. This may partially account for the higher rate of limb loss in AA patients
with peripheral arterial occlusive disease. ( J Vasc Surg 2005;:.)African Americans (AAs)—in particular, women—have
an increased risk for developing diabetes mellitus (DM) and
peripheral arterial occlusive disease (PAOD).1-4 Several
studies have shown that AA patients with PAOD were more
likely to lose their limbs compared with Caucasian patients
with PAOD.5-9 The reasons for this disparity in outcomes
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doi:10.1016/j.jvs.2005.06.012of infrainguinal occlusive disease between the two racial
groups are unclear. Possible contributory factors include
differences between the two racial groups with respect to
the severity of the vascular occlusive disease, access to
health care, educational level (influencing the patient’s
understanding of the disease), socioeconomic status, and
compliance with the medical treatment of risk factors for
atherosclerosis.
Arterial bypass grafting with autogenous vein is an
effective operation for limb salvage (LS) in patients with
critical limb ischemia. The long-term results of infraingui-
nal arterial reconstruction with greater saphenous vein
(GSV) have been well established: the 5-year primary pa-
tency (PP) is 70%, secondary patency (SP) is 80%, and LS is
80% to 90%.10-12 However, the results of autogenous in-
frainguinal arterial reconstruction in AA, and whether race
has any influence on graft patency and LS rates, are unclear.
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in risk factor profiles and severity of disease at presentation
and to compare the results of autogenous infrainguinal
bypasses with respect to graft patency and LS rates between
AA and Caucasian patients.
METHODS
All patients undergoing treatment of vascular disease at
the Division of Vascular and Endovascular Surgery at the
Brigham and Women’s hospital are prospectively entered
into a computerized vascular registry. The vascular registry
has been actively maintained since 1975 and collects data
on patients with respect to demographics, risk factors,
indications for surgery, type of procedure, perioperative
morbidity and mortality, graft patency, LS and survival
rates, use of antithrombotics, and so on. From this registry,
a retrospective cohort study was performed on all AA and
Caucasian patients who had undergone autogenous in-
frainguinal bypass grafting from January 1, 1985, to
December 31, 2003. To avoid potential double counting
of events in patients who may be genetically predisposed to
graft failure and who undergo bilateral lower limb bypasses,
only single-limb bypasses in each patient cohort were con-
sidered in this analysis. In patients who had undergone
bilateral lower limb bypasses, the first limb bypass was
chosen as the index bypass procedure. Medical records
were also reviewed to determine the possible causes of
failure of the vein grafts and the use of medications for the
control of risk factors for atherosclerosis (statin therapy,
beta-blockers, aspirin, clopidogrel, or warfarin) at the time
of admission and on discharge from the hospital after
bypass surgery.
The techniques of autogenous infrainguinal arterial
reconstruction that are practiced by this group have been
previously published.11,13 In summary, the chosen inflow
artery should be free of any significant proximal disease, and
the outflow artery should be the least diseased vessel that
provides the best distal perfusion to the foot. The conduit
of first choice was the GSV, which was used in either the
reversed (when there was no significant change in the
caliber of the vein) or the nonreversed (transposed or in
situ) configuration. In the absence of usable GSV, arm
veins (cephalic and basilic veins) and lesser saphenous vein
were used as either single-segment or composite vein grafts.
In these cases, vein mapping with duplex ultrasonography
guided the prioritization strategy for exploration of these
alternative veins in the operating room. The criteria for an
acceptable vein segment were a minimum diameter of 3.5
mm, easy distensibility with gentle irrigation, and absence
of sclerotic or thrombosed areas. Vein segments that did
not meet these criteria were excised or repaired. Comple-
tion angiography was routinely performed in all cases.
Recently, we have also used intraoperative duplex imaging
to detect occult problems in the vein graft. After surgery,
patients were maintained on lifelong aspirin unless this was
contraindicated. Anticoagulation was used selectively only
in patients with a documented hypercoagulable state or
when the bypass graft was believed to be at high risk forthrombosis. Graft surveillance with duplex ultrasonogra-
phy was performed at 1 month and then at 3-month
intervals for the first year and at 6-month intervals thereaf-
ter. A recurrence of symptoms, a change in the character of
the graft or distal pulses, or a decrease in the ankle-brachial
index greater than 0.1 or pulse volume recording wave-
forms was an indication of possible graft stenosis. Duplex
criteria of impending graft failure included decreased over-
all graft velocity (peak systolic velocity 25 cm/s in a
normal-caliber graft) or a focal increase in velocity (peak
systolic velocity 300 cm/s or an increase in peak systolic
velocity in one segment of the bypass greater than three
times that of an adjacent segment). This usually led to
arteriography and graft revision as indicated.
Minor amputations were defined as those resulting in a
foot that could still be used for ambulation. LS was corre-
spondingly defined as freedom from transtibial or above-
knee amputation. PP, assisted primary patency (APP), and
SP rates were defined in accordance with the suggested
reporting standards of the Society for Vascular Surgery/
International Society for Cardiovascular Surgery Ad Hoc
Committee.14 Continuous variables were compared by us-
ing the Student t test, and categorical variables were com-
pared by using the Fisher exact test. Graft patency, LS, and
patient survival rates were analyzed with the life-table
method and log-rank test. Multivariate analysis of demo-
graphic and medical factors (age, sex, race, DM, smoking,
hypertension, coronary artery disease, prior coronary by-
pass surgery, stroke, chronic obstructive lung disease, renal
failure, indications for surgery, order of operation, and sites
of proximal and distal anastomoses) affecting graft patency
and LS outcomes was performed with a Cox proportional
hazard model. An  value of .05, corresponding to P .05
and 95% confidence intervals, was used as a criterion for
statistical significance. Loss to follow-up was defined as the
last patient visit or contact after 18 months. Statistical
computations were performed with Statistica 6.1 (StatSoft,
Tulsa, Okla) and SAS 8.02 (SAS Institute, Cary, NC).
RESULTS
From January 1, 1985, to December 31, 2003, 1459
infrainguinal arterial bypasses with autogenous vein were
performed in 1459 patients for lower limb ischemia. Within
this group, 89 AA patients (6% of the study population)
underwent 89 autogenous infrainguinal reconstructions;
these patients formed the study cohort. The control group
comprised 1370 Caucasian patients (94% of the study
population) who underwent 1370 autogenous infraingui-
nal reconstructions within the same time period. Table I
summarizes the demographics and risk factor profiles for
both groups. AA patients (median age, 65 years; range,
35-88 years) were significantly younger (P  .001) than
Caucasian patients (median age, 70 years; range, 19-96
years) and were predominantly female (AA, 57%; Cauca-
sian, 41%; P  .002). Furthermore, AA patients had a
significantly higher prevalence of DM, hypertension, con-
gestive heart failure, history of stroke, renal insufficiency,
and dialysis-dependent renal failure compared with Cauca-
heno
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both cohorts were mainly for LS (AA, 91%; Caucasian,
80%; P .01). However, more AA patients presented with
advanced tissue loss (digital or forefoot gangrene) com-
pared with Caucasian patients (34% vs 16%; P  .001).
Eighty-nine percent of the bypasses in the AA cohort and
83% of the bypasses in the Caucasian cohort were primary
operations (P  .18).
Most bypass grafts originated at the common femoral
artery (AA, 62%; Caucasian, 66%; P  .4). The site of the
distal anastomosis was at the tibial/pedal level in 67% of AA
and 61% of Caucasian patients (P  .2). Table II summa-
rizes the characteristics of the bypass grafts. The types of
venous conduit used were single-segment GSV (AA, 83%;
Caucasian, 85%; P  .7), autogenous composite vein (AA,
16%; Caucasian, 12%; P  .3), single-segment arm vein
(AA, 1%; Caucasian, 2%; P .4), and lesser saphenous vein
(AA, 0%; Caucasian, 1%; P  .3). The overall 30-day
postoperative morbidity was similar in both groups (AA,
28%; Caucasian, 23%; P  .2). The 30-day operative mor-
Table I. Demographics and risk factor profile
Variable
African America
(n  89)
Median age (y) 65
Male/female, n (%) 38/51 (43/57)
Diabetes mellitus, n (%) 56 (63)
Smoking, n (%) 30 (34)
Hypertension, n (%) 74 (83)
Coronary disease, n (%) 37 (42)
Heart failure, n (%) 21 (24)
Stroke, n (%) 19 (21)
Renal failure, n (%) 30 (34)
Dialysis dependence, n (%) 16 (18)
Table II. Characteristics of the bypass grafts
Variable
African Ame
n (%)
Primary reconstructions 79 (89
Indication: claudication 8 (9)
Indication
Limb salvage 81 (91
Rest pain 28 (32
Ulcer 23 (26
Gangrene 30 (34
PANA
Common femoral 55 (62
Superficial femoral 16 (18
Popliteal 18 (20
Profunda femoral 0 (0)
DANA
Tibial/pedal artery 60 (67
Single-segment GSV 74 (83
Arm vein 1 (1)
Lesser saphenous vein 0 (0)
Autogenous composite vein 14 (16
PANA, Proximal anastomosis; DANA, distal anastomosis; GSV, greater saptality was also similar in both groups (AA, 3%; Caucasian,3%; P  .6). The 30-day graft failure rate was significantly
higher in AA patients compared with Caucasian patients
(AA, 12%; Caucasian, 5%; P  .003). The causes of early
graft failure in the AA group were mainly poor-quality vein
grafts, poor arterial outflow due to severe distal disease, or
indeterminate (Table III).
The duration of follow-up was as follows: AA—mean,
33 months; median, 22 months; and range, 0.1-156
months; Caucasian—mean, 43 months; median, 26
months; and range, 0-228 months. Loss to follow-up was
significantly different: 5% AAs vs 12% Caucasians (P .04).
The number of patients who underwent postoperative graft
surveillance with duplex ultrasonography was higher in the
AA cohort. Sixty-one percent of AA and 45% of Caucasian
patients received one or more duplex scans of their bypass
grafts within the first postoperative year (P  .004). A
significantly greater number of AA patients required one or
more revisions of their bypass grafts compared with Cauca-
sian patients (AA, 30%; Caucasian, 16%; P  .001). Also,
more AA patients required multiple (two or more) graft
Caucasian
(n  1370) P value
70 .001
813/557 (59/41) .002
656 (48) .006
513 (37) .5
849 (62) .001
689 (50) .1
114 (8) .001
157 (11) .006
173 (13) .001
84 (6) .001
, Caucasian,
n (%) P value
1141 (83) .18
267 (20) .01
1103 (80) .01
431 (31) .99
453 (33) .16
219 (16) .001
901 (66) .4
283 (21) .5
159 (12) .02
27 (2) .2
834 (61) .2
1157 (85) .7
32 (2) .4
14 (1) .3
167 (12) .3
us vein.nrican
)
)
)
)
)
)
)
)
)
)
)revisions compared with Caucasian patients (AA, 17%;
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medications for the control of risk factors for atherosclero-
sis, significantly more AA patients had antithrombotics
(aspirin, clopidogrel, or warfarin), -blockers, or statin
therapy prescribed after bypass surgery compared with
Caucasian patients (Fig 1).
The overall 5-year cumulative PP (SE) was signifi-
cantly worse in AA compared to Caucasian patients (AA,
52%  6%; Caucasian, 67%  2%; P  .009; Table IV).
Significant divergence of the PP curves occurred at 30 days
(this was due to the higher early graft failure in the AA
cohort) and also at 12 months after bypass surgery (Fig 2).
The 5-year APP and SP rates were not significantly different
between cohorts. Despite similar long-term APP and SP
rates, the 5-year LS rate (SE) was still significantly worse
in AA compared with Caucasian patients (AA, 81%  5%;
Caucasian, 90%  1%; P  .04; Table IV). This suggests
that other factors, apart from the patency of the bypass
graft, may be determining a higher rate of limb loss in AA
patients compared with Caucasian patients. Significant di-
vergence of the LS curves occurred at 12 and 48 months
(Fig 3).
Multivariate analysis by using the Cox proportional
hazard model resulted in several predictors of primary graft
failure: age younger than 65 years (hazard ratio [HR],
1.25; P .038), female sex (HR, 1.25; P .035), AA race
(HR, 1.74; P  .002), when the index operation was a
secondary operation (HR, 1.58; P  .0003), when the
Fig 1. Use of medications by racial groups after bypass surgery.
Table III. Causes of early (30-day) graft failure in the
African American cohort
Cause n (%)
Technical 1 (8)
Poor-quality vein graft 4 (34)
Poor arterial outflow 3 (25)
Platelet thrombus 1 (8)
Unknown 3 (25)indication was rest pain (vs claudication; HR, 1.28; P .018), and when the distal anastomosis was at the anterior
tibial (vs popliteal; HR, 1.52; P  .006) or posterior tibial
(HR, 1.34; P  .04) arteries (Table V). Because more
30-day graft failures were observed in the AA group, we
added a time-varying covariate to the Cox proportional
hazard model to test whether the HR was different between
the patients who experienced treatment failure at or before
Fig 2. Overall primary graft patency by race.
Fig 3. Overall limb salvage by race.
Table IV. Overall 5-year graft patency, limb salvage, and
survival by race (SE)
Variable
African
American Caucasian P value
Primary patency 52%  6% 67%  2% .009
Assisted primary patency 71%  10% 78%  1% .23
Secondary patency 73%  6% 80%  1% .11
Limb salvage 81%  5% 90%  1% .04
Survival 61%  6% 56%  2% .2030 days and those who experienced treatment failure after
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in the later-failure group, this did not approach statistical
significance (P  .26). Therefore, the association of AA
race with primary graft failure was not limited only to the
early (30-day) period, but was also present beyond 30 days
after bypass.
The predictors for limb loss were age younger than 65
years (HR, 1.47; P  .039); female sex (HR, 1.47; P 
.036); absence of coronary artery disease (HR, 1.61; P 
.026); rest pain (HR, 3.44;  P  .012), ulcer (HR, 6.66;
P  .0001), or gangrene (HR, 11.24; P  .0001) as the
indication for surgery (vs claudication); and when the index
operation was a secondary operation (HR, 2.17; P 
.0004; Table VI). Although AA race was a predictor of
primary graft failure, it was not a significant predictor for
limb loss.
DISCUSSION
The main findings of this study of infrainguinal bypass
surgery in AA and Caucasian patients were as follows. (1)
AA patients with lower limb ischemia were younger, were
predominantly female, and had a greater prevalence of DM,
hypertension, and dialysis-dependent renal failure. (2)
More AA patients had advanced critical limb ischemia
manifesting as gangrene. (3) Overall 5-year PP of infrain-
guinal bypass grafts was worse in AA patients. (4) Overall
5-year LS was worse in AA patients.
The outcomes of lower extremity atherosclerotic occlu-
sive disease are markedly different between AA and Cauca-
sian patients.5-9 The reasons for a greater rate of limb loss in
Table V. Predictors of primary graft failure
Variable Hazard ratio P value
Age 65 y 1.25 .038
Female sex 1.25 .035
African American race 1.74 .002
Secondary bypass 1.58 .0003
Indication: rest pain* 1.28 .018
DANA: anterior tibial 1.52 .006
DANA: posterior tibial 1.34 .041
DANA, Distal anastomosis (hazard ratio relative to DANA at popliteal
artery).
*Indication: hazard ratio relative to indication of claudication.
Table VI. Predictors of limb loss
Variable Hazard ratio P value
Age 65 y 1.47 .039
Female sex 1.47 .036
No CAD 1.61 .026
Secondary bypass 2.17 .0004
Indication
Rest pain 3.44 .012
Ulcer 6.66 .0001
Gangrene 11.24 .0001
CAD, Coronary artery disease.AA patients with PAOD are not well understood. Studiesbased on statewide hospital discharge databases and Medi-
care claims data have shown that AA patients were less likely
to undergo lower extremity revascularization and were
more likely to undergo major amputation compared with
Caucasian patients.6,8,9,15 Whether this is due to a greater
severity of distal disease or to an underuse of bypass surgery
in AA patients is unclear. Large studies of these designs,
however, have many other variables that may contribute to
the disparate outcomes between the two racial groups, such
as differences with respect to access to health care, severity
and distribution of disease at presentation, varying capabil-
ities for advanced vascular reconstruction of the numerous
hospitals, and racial bias among health care providers. This
study did not have some of these limitations because it was
performed at a single institution by an established group of
vascular surgeons who have a uniform, aggressive policy
toward LS in all patients who present with lower limb
ischemia.
Our first observation was that AA patients with lower
limb ischemia were significantly younger than the Cauca-
sian cohort and were predominantly female. Furthermore,
medical comorbidities (DM, hypertension, congestive
heart failure, stroke, and renal failure) were more prevalent
in AA patients; this may explain the similar 5-year survival in
both cohorts despite the younger age of the AA patients.
Second, more AA patients presented with digital or
forefoot gangrene, thus suggesting more advanced critical
limb ischemia in this cohort. The reasons for this are
unknown, and possible contributory factors include (1) a
greater prevalence of DM and associated peripheral neu-
ropathy in AA patients, thus resulting in the absence of rest
pain; (2) delayed recognition of the severity of disease by
AA patients; (3) poor access to health care in AA patients;
and (4) greater severity of arterial occlusive disease in AA
patients. It is interesting to note that one study that evalu-
ated arteriograms in well-matched patients with lower ex-
tremity ischemia found significantly more severe infra-
genicular occlusive disease in AA patients compared with
Caucasian patients, thus suggesting a more aggressive form
of atherosclerosis in the former group.16
Third, the 5-year PP was significantly worse in AA than
in Caucasian patients. The higher early (30-day) graft fail-
ure rate in the AA cohort only partially accounted for this
difference in PP between groups. A second significant
decrease in patency occurred at the 12-month interval, thus
suggesting that AA patients may have a higher mid-term
graft failure rate than Caucasian patients. The Cox propor-
tional hazard model, using a time-varying covariate, also
confirmed that the association of AA race with primary graft
failure was not limited only to the early period but was
present beyond the 30-day postbypass interval as well.
Given that the most common cause of mid-term failure of
vein grafts is myointimal hyperplasia and that the graft
revision rate in the AA cohort in this study was significantly
greater than in the Caucasian cohort, one hypothesis is that
vein bypass grafts in AA patients, compared with Caucasian
patients, are more susceptible to the formation of myointi-
mal hyperplasia. Future studies looking at the causes of
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groups will be necessary to confirm this.
On multivariate analysis, the significant predictors of
primary graft failure were age younger than 65 years, female
sex, AA race, when the index operation was a secondary
bypass, when the indication for bypass was rest pain (vs
claudication), and when the distal anastomosis was at the
tibial arteries (vs popliteal artery). Previous studies have
corroborated the unfavorable influence of young age, fe-
male sex, secondary reconstructions, and tibial bypasses on
graft patency.17-23 To our knowledge, however, this is the
first study identifying race (AA) as predictive for primary
graft failure. There is a paucity of data in the literature
comparing the results of infrainguinal bypass grafting in AA
and Caucasian patients. One other study, by Brothers et al,3
found no significant difference in the 3-year PP but found a
significantly worse LS for AA patients compared with Cau-
casian patients.
Finally, the 5-year LS was significantly worse in AA
compared with Caucasian patients. Despite similar APP and
SP rates, the LS rate was still significantly worse in AA
patients. This suggests that other factors, apart from pa-
tency of the bypass graft, may be determining the relatively
higher rate of limb loss in AA patients. It is interesting to
note that divergence of the LS curves between the two
groups occurred relatively late, at the 12- and 48-month
intervals after bypass surgery. Possible reasons for this may
be late progression of distal disease in AA patients or
diabetic foot infections. Future studies should evaluate the
indications for major amputations in both patient cohorts
to better understand the reasons for the more frequent limb
loss in AA patients. Multivariate analysis identified the
following significant predictors for limb loss: age younger
than 65 years, female sex, absence of coronary artery dis-
ease, critical limb ischemia as the indication for surgery, and
when the index operation was a secondary bypass. It is
interesting to note that although AA race was a predictor of
primary graft failure, it was not a significant predictor for
limb loss. Therefore, the higher rate of limb loss in AA
patients in this study may be related to the younger age of
the patients, the greater proportion of women, and the
higher incidence of gangrene at presentation, because the
distribution of the other two variables (coronary artery
disease and secondary bypass) were not significantly differ-
ent between the two cohorts.
The limitations of this study lie in its retrospective
design and the inability to prospectively control for patient
variables between the comparison groups. Also, although
all AA patients who underwent infrainguinal bypasses in the
same time period were included in this analysis, the AA
patient cohort was relatively small and comprised only 6%
of our total study population. Therefore, this study is
primarily reflective of the demographics of the AA patients
at our tertiary care referral institution. We recognize that in
institutions that care for significantly more AA patients, the
demographics of their AA patients may differ from ours.
Finally, the effect of disease awareness and socioeconomic
status of patients were not evaluated in this study but maybe important and partially responsible for the greater inci-
dence of gangrene and limb loss in AA patients.
In conclusion, we have shown that autogenous in-
frainguinal bypass surgery in AA patients—compared
with Caucasians—is associated with poorer PP and LS
rates. The poorer LS rate in AAs is likely related to their
younger age, greater proportion of women, and higher
incidence of gangrene at the time of bypass surgery. These
differences between the two racial groups may partially
account for the disparate outcomes and greater likelihood
of limb loss in AA patients with PAOD than in Caucasian
patients.
The authors are grateful to Julie Lombara for her
assistance in data acquisition and analysis and maintenance
of the vascular registry and to Lorens Helmchen for his
detailed review of the statistical methods.
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Life table of overall primary graft patency in the African American cohort
Period
(mo)
No. grafts
at risk
No. grafts
failing
No. grafts
lost
No. grafts
withdrawn
% Interval
failure
% Interval
patency
% Cumulative
patency SE
0-1 89 12 0 3 13.7 86.3 86.3 3.7
1-3 74 7 0 4 9.7 90.3 77.9 4.4
3-6 63 5 0 3 8.1 91.9 71.6 4.9
6-12 55 10 0 5 19.0 81.0 58.0 5.5
12-24 40 1 1 8 2.8 97.2 56.4 5.2
24-36 30 2 1 2 7.0 93.0 52.4 5.9
36-48 25 0 0 7 0 100 52.4 5.9
48-60 18 0 0 2 0 100 52.4 5.9
Appendix II
Life table of overall primary graft patency in the Caucasian cohort
Period
(mo)
No. grafts
at risk
No. grafts
failing
No. grafts
lost
No. grafts
withdrawn
% Interval
failure
% Interval
patency
% Cumulative
patency SE
0-1 1370 77 14 56 5.8 94.2 94.2 0.6
1-3 1223 66 9 61 5.6 94.4 88.9 0.9
3-6 1087 70 8 68 6.7 93.3 83.0 1.1
6-12 941 61 19 82 6.8 93.2 77.3 1.2
12-24 779 41 13 106 5.7 94.3 72.9 1.3
24-36 619 19 10 88 3.3 96.7 70.5 1.4
36-48 502 14 7 73 3.0 97.0 68.4 1.5
48-60 408 9 11 62 2.4 97.6 66.8 1.5
Appendix III
Life table of overall limb salvage in African American cohort
Period
(mo)
No. limbs
at risk
No. limbs
amputated
No. limbs
withdrawn
% Interval
amputation
% Interval limb
salvage
% Cumulative
limb salvage SE
0-1 89 1 3 1.1 98.9 98.9 1.1
1-3 85 0 4 0 100 98.9 1.1
3-6 81 4 3 5.0 95.0 94.0 2.6
6-12 74 4 5 5.6 94.4 88.7 3.6
12-24 65 1 13 1.7 98.3 87.2 3.8
24-36 51 1 7 2.1 97.9 85.4 4.2
36-48 43 2 10 5.3 94.7 80.8 5.0
48-60 31 0 5 0 100 80.8 5.0
Appendix IV
Life table of overall limb salvage in Caucasian cohort
Period
(mo)
No. limbs
at risk
No. limbs
amputated
No. limbs
withdrawn
% Interval
amputation
% Interval
limb salvage
% Cumulative
limb salvage SE
0-1 1370 24 63 1.8 98.2 98.2 0.4
1-3 1283 22 63 1.8 98.2 96.4 0.5
3-6 1198 21 81 1.8 98.2 94.7 0.6
6-12 1096 14 118 1.4 98.6 93.4 0.7
12-24 964 12 157 1.4 98.6 92.1 0.8
24-36 795 5 132 0.7 99.3 91.4 0.8
36-48 658 6 103 1.0 99.0 90.5 0.9
48-60 549 5 102 1.0 99.0 89.6 1.0
